For the year ending 2025-12-31, HIMS had $7,176K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income (loss) | 128,365 | 126,038 | -23,546 | -65,678 |
| Depreciation and amortization | 54,502 | 17,088 | 9,515 | 7,474 |
| Stock-based compensation | 135,244 | 92,322 | 66,080 | 42,817 |
| Change in fair value of liabilities | - | 0 | -1,075 | 70 |
| Warrant expense in connection with merger | - | - | 0 | 0 |
| Lease termination expense | - | - | - | 0 |
| Change in fair value of equity securities | 4,437 | - | - | - |
| Amortization of debt issuance costs | - | - | 0 | 0 |
| Change in fair value of liabilities | 9,255 | - | - | - |
| Net accretion on securities | 2,032 | 4,355 | 5,686 | -146 |
| Benefit from deferred taxes | -12,961 | -61,649 | -13 | -594 |
| Impairment of long-lived assets | 531 | 114 | 429 | 1,127 |
| Amortization of debt discount and issuance costs | 4,529 | - | - | - |
| Non-cash operating lease cost | -12,413 | -2,546 | -1,922 | -1,605 |
| Non-cash acquisition-related costs | 5,893 | 0 | 2,691 | 837 |
| Non-cash other | 2,135 | -357 | -195 | 0 |
| Inventory | 13,722 | 41,612 | 902 | 8,004 |
| Prepaid expenses and other current assets | 51,856 | 9,494 | 6,395 | 6,335 |
| Other long-term assets | 518 | 56 | 58 | -17 |
| Accounts payable | 30,297 | 43,710 | 7,324 | 12,723 |
| Accrued liabilities | -43,053 | 23,791 | 16,524 | 909 |
| Deferred revenue | 51,604 | 67,552 | 6,261 | -1,716 |
| Operating lease liabilities | -1,913 | -2,443 | -1,933 | -1,605 |
| Earn-out payable | 0 | -2,825 | 0 | -10,184 |
| Other long-term liabilities | - | - | - | 0 |
| Net cash provided by operating activities | 300,006 | 251,084 | 73,483 | -26,531 |
| Purchases of available-for-sale investments | 725,838 | 160,564 | 157,239 | 187,700 |
| Maturities of available-for-sale investments | 108,698 | 208,940 | 170,051 | 194,259 |
| Proceeds from sales of available-for-sale investments | 0 | 725 | 1,574 | 35,846 |
| Investment in website development and internal-use software | 16,546 | 11,095 | 9,272 | 4,533 |
| Purchases of property, equipment, and intangible assets | 226,045 | 41,655 | 17,220 | 2,714 |
| Deferred consideration paid for acquisitions | - | 0 | 0 | 459 |
| Acquisition of businesses, net of cash acquired | 145,227 | 15,399 | 0 | 0 |
| Purchase of equity securities | 20,000 | - | - | - |
| Net cash used in investing activities | -1,024,958 | -19,048 | -12,106 | 34,699 |
| Proceeds from issuance of convertible senior notes, net of debt discount | 970,000 | - | - | - |
| Proceeds from exercise of vested stock options | - | 26,651 | 2,322 | 2,246 |
| Purchases of capped calls related to convertible senior notes | -47,800 | - | - | - |
| Repayments of principal on term loan | - | - | - | 0 |
| Proceeds from exercise of vested stock options | 11,033 | - | - | - |
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | 0 |
| Payments for taxes related to net share settlement of equity awards | 116,669 | 52,501 | 14,096 | 3,901 |
| Repurchases of common stock | 89,960 | 83,039 | 1,999 | 0 |
| Pre-closing stock repurchase | - | - | 0 | - |
| Proceeds from issuance of common stock upon merger | - | - | 0 | 0 |
| Proceeds from pipe | - | - | 0 | 0 |
| Payments for transaction costs related to securities issuances | - | - | 0 | 0 |
| Proceeds from employee stock purchase plan | 6,440 | 3,901 | 2,298 | 1,178 |
| Proceeds from repayment of promissory notes associated with vested and unvested shares | - | - | 0 | 0 |
| Payments for debt issuance costs | 3,424 | - | - | - |
| Proceeds from exercise of series c preferred stock warrants | - | - | - | 0 |
| Payments for acquisition-related earn-out consideration | 0 | 3,190 | 0 | 32,650 |
| Proceeds from exercise of class a common stock warrants | 0 | 333 | 0 | 0 |
| Net cash provided by (used in) financing activities | 729,620 | -107,845 | -11,475 | -33,127 |
| Foreign currency effect on cash and cash equivalents | 2,508 | -270 | -11 | -53 |
| Increase in cash, cash equivalents, and restricted cash | 7,176 | 123,921 | 49,891 | -25,012 |
| Cash, cash equivalents, and restricted cash at beginning of period | 221,440 | 97,519 | 47,628 | 72,640 |
| Cash, cash equivalents, and restricted cash at end of period | 228,616 | 221,440 | 97,519 | 47,628 |
Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (HIMS)